Characteristics of a COPD population categorised using the GOLD framework by health status and exacerbations

Respiratory Medicine

Volumn 108, Issue 1, 2014, Pages 129-135

  Jones, Paul W ^a   Nadeau, Gilbert ^b   Small, Mark ^c   Adamek, Lukasz ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c ADELPHI REAL WORLD   (United Kingdom)

Author keywords

CAT; COPD; Exacerbations; GOLD

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DIABETES MELLITUS; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; LOW RISK POPULATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MIDDLE AGED; MODIFIED MRC DYSPNEA SCALE; PRIORITY JOURNAL; RATING SCALE; SPIROMETRY; SYMPTOMATOLOGY;

CAT; COPD; EXACERBATIONS; GOLD;

AGED; COMORBIDITY; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; EUROPEAN UNION; FEMALE; FORCED EXPIRATORY VOLUME; FRANCE; GERMANY; GREAT BRITAIN; HEALTH STATUS; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPAIN; SPIROMETRY;

EID: 84893671688     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.08.015     Document Type: Article

References (26)

1. A. Agusti, P. Calverley, and B. Celli et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort Respir Res 11 2010 122 136
2. K.F. Rabe, S. Hurd, and A. Anzueto et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 176 2007 532 555
3. Global initiative for chronic obstructive lung disease (GOLD) 2011 Available from: http://www.goldcopd.org/ [accessed 25.05.12]
4. J.R. Hurst, J. Vestbo, and A. Anzueto et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease N Engl J Med 363 2010 1128 1138
5. P.W. Jones, G. Harding, and P. Berry et al. Development and first validation of the COPD assessment test Eur Respir J 34 2009 648 654
6. P.W. Jones, G. Brusselle, and R.W. Dal Negro et al. Properties of the COPD assessment test in a cross-sectional European study Eur Respir J 38 2011 29 35
7. C.M. Fletcher The clinical diagnosis of pulmonary emphysema-an experimental study Proc R Soc Med 45 1952 577
8. J.C. Bestall, E.A. Paul, R. Garrod, R. Garnham, P.W. Jones, and J.A. Wedzicha Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease Thorax 54 1999 581 586
9. P. Lange, J.L. Marott, J. Vestbo, K.R. Olsen, T.S. Ingebrigtsen, M. Dahl, and B.G. Nordestgaard Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population Am J Respir Crit Care Med 186 2012 975 981
10. M.K. Han, H. Muellerova, and D. Curran-Everett et al. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study Lancet Respir Med 2012 10.1016/S2213-2600(12)70044-9 September online
11. J.B. Soriano, I. Alfageme, P. Almagro, C. Casanova, C. Esteban, J.J. Soler-Cataluña, J.P. de Torres, P. Martinez-Camblor, M. Miravitlles, B.R. Celli, and J.M. Marin Distribution and prognostic validity of the new GOLD grading classification Chest 2012 Sep 10 10.1378/chest.12-1053
12. P. Anderson, M. Benford, and N. Harris et al. Real-world physician and patient behaviour across countries: disease-specific programmes - a means to understand Curr Med Res Opin 24 2008 3063 3072
13. EphMRA code of conduct for international healthcare market research, last update 10th September 2010.
14. P.W. Jones, L. Adamek, G. Nadeau, and N. Banik Comparisons of health status scores with MRC grades in a primary care COPD population: implications for the new GOLD 2011 classification ERJ 2012 10.1183/09031936.00125612 [Epub ahead of print Dec 12th]
15. P.W. Jones, M. Tabberer, and W.-H. Chen Creating scenarios of the impact of COPD and their relationship to COPD assessment test (CAT™) scores BMC Pulm Med 11 2011 42
16. M. Miravitlles, J.B. Soriano, F. García-Río, L. Muñoz, E. Duran-Tauleria, G. Sanchez, V. Sobradillo, and J. Ancochea Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities Thorax 64 2009 863 868
17. C.G. Cote, L.J. Dordelly, and B.R. Celli Impact of COPD exacerbations on patient-centered outcomes Chest 131 2007 696 704
18. P.S. Burge, P.M. Calverley, P.W. Jones, S. Spencer, J.A. Anderson, and T.K. Maslen Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial BMJ 320 2000 1297 1303
19. J.A. Wedzicha, P.M. Calverley, T.A. Seemungal, G. Hagan, Z. Ansari, and R.A. Stockley INSPIRE Investigators. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide Am J Respir Crit Care Med 177 2008 19 26 [Epub 2007 Oct 4]
20. P.M. Calverley, W. Boonsawat, Z. Cseke, N. Zhong, S. Peterson, and H. Olsson Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease Eur Respir J 22 2003 912 919
21. B.R. Celli, N.E. Thomas, and J.A. Anderson et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study Am J Respir Crit Care Med 178 2008 332 338
22. Global initiative for chronic obstructive lung disease (GOLD) 2013 Available from: http://www.goldcopd.org/ [accessed 5.03.13]
23. K. Schnell, C.O. Weiss, T. Lee, J.A. Krishnan, B. Leff, J.L. Wolff, and C. Boyd The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008 BMC Pulm Med 12 2012 26
24. D.M. Mannino, D. Thorn, A. Swensen, and F. Holguin Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Eur Respir J 32 2008 962 969
25. P.W. Jones, G. Brusselle, R.W. Dal Negro, M. Ferrer, and P. Kardos et al. Health-related quality of life in patients by COPD severity within primary care in Europe Respir Med 105 2011 57 66
26. A. Agusti, S. Hurd, and P. Jones et al. Frequently asked questions about the GOLD 2011 assessment proposal: a comparative analysis of four different cohorts Eur Respir J 2013; May 3 [Epub ahead of print]